A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males

NCT02484729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Pharmacokinetics
Healthy Subjects

Interventions

DRUG: AZD9977, oral suspension
DRUG: Placebo, oral suspension
DRUG: AZD9977, oral solution

Sponsor

AstraZeneca